SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Galena Biopharma (GALE)

I sold my last shares of Gale this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
noretreat Member Profile
 
Followed By 121
Posts 10,048
Boards Moderated 2
Alias Born 01/06/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/18/2017 5:16:20 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 6:02:42 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 6:00:23 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 5:58:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 5:55:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 5:52:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 5:50:10 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/10/2017 5:46:18 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/2/2017 10:09:06 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) "Edgar (US Regulatory)" - 10/2/2017 10:06:11 AM
SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA "PR Newswire (US)" - 10/2/2017 7:35:00 AM
SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA "PR Newswire (US)" - 10/2/2017 7:35:00 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) "Edgar (US Regulatory)" - 9/29/2017 5:10:34 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/29/2017 5:09:12 PM
Galena Biopharma Announces Completion of Enrollment in Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Tras... "GlobeNewswire Inc." - 9/28/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/25/2017 5:19:22 PM
Securities Registration: Business Combination (s-4) "Edgar (US Regulatory)" - 9/22/2017 5:26:09 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/14/2017 9:14:09 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) "Edgar (US Regulatory)" - 9/14/2017 9:12:21 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) "Edgar (US Regulatory)" - 9/11/2017 7:51:02 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 7:21:43 AM
Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership "GlobeNewswire Inc." - 9/11/2017 7:05:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/14/2017 5:31:45 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) "Edgar (US Regulatory)" - 8/14/2017 5:00:56 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/14/2017 4:57:37 PM
noretreat   Friday, 02/14/14 10:25:43 AM
Re: None
Post # of 10445 
I sold my last shares of Gale this morning, after lightening up by 90% over the previous month. It looks like these issues aren't going to go away quickly, and management does not seem to want to address them. Riding the run-up was nice.

Does not look like the CLDX of 2014 anymore, but who knows? There should be a bounce here a some point.


Men fear thought as they fear nothing else on earth -- more than ruin, more even than death. Thought is subversive and revolutionary, destructive and terrible, thought is merciless to privilege, established institutions, and comfortable habits.(Russell)
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist